Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 70,810 | 65,110 | 51,611 | 50,165 | 39,986 |
| Operating Income | -70,810 | -65,110 | -51,611 | -50,165 | -39,986 |
| Other Income | 1,215 | 1,542 | 2,124 | 2,614 | 3,036 |
| Pre-tax Income | -69,595 | -63,568 | -49,487 | -47,551 | -36,950 |
| Net Income Continuous | -69,595 | -63,568 | -49,487 | -47,551 | -36,950 |
| Net Income | $-69,595 | $-63,568 | $-49,487 | $-47,551 | $-36,950 |
| EPS Basic Total Ops | -0.55 | -0.51 | -0.40 | -0.38 | -0.30 |
| EPS Basic Continuous Ops | -0.55 | -0.51 | -0.40 | -0.38 | -0.30 |
| EPS Diluted Total Ops | -0.55 | -0.51 | -0.40 | -0.38 | -0.30 |
| EPS Diluted Continuous Ops | -0.55 | -0.51 | -0.40 | -0.38 | -0.30 |
| EBITDA(a) | $-70,608 | $-65,202 | $-51,901 | $-51,074 | $-40,947 |